Transconjunctival vs Transcutaneous Anaesthesia in Oculoplastics
Comparative Study of Transconjunctival vs. Transcutaneous Routes for Administration of Local Anaesthesia in Oculoplastic Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
Eyelid surgery is commonly performed under local anaesthesia. For many such procedures, the local anaesthetic injection may be given either transcutaneously (through the skin) or transconjunctivally (through the conjunctiva, i.e. from the inner surface of the eyelid after administration of topical anaesthetic drops). Both methods are commonly used, sometimes in combination. Currently, the choice of route is largely determined by surgeon preference, but it is not known whether one method is better or more comfortable than the other. Our study will compare the two methods of local anaesthetic administration, in terms of patient comfort during anaesthetic administration, efficacy (i.e. whether any additional anaesthetic is needed during surgery), and adverse effects (e.g. bruising, postoperative double vision). We will recruit adult patients who are due to undergo eyelid surgery on both sides under local anaesthesia, on Miss Siah's lists at Southampton General Hospital or Lymington Hospital. Patients will receive topical anaesthetic eye drops to both eyes, followed by an injection of local anaesthetic to each eyelid. One side will be administered transcutaneously, and the other side transconjunctivally. The order be randomised. After the injections, participants will be asked to rate their pain levels during each injection on a standardised numerical scale (1-10). A photograph will also be taken, so that an independent assessor can subsequently rate the extent of any bruising. The eyelid surgery will then be performed as normal, with any need for further anaesthetic during the surgery being recorded. Patients will attend for their normal follow-up appointment afterwards and any postoperative complications will be recorded, but the study will not require any extra hospital visits. The study is sponsored by University Hospitals NHS Foundation Trust, but does not have any external funding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 5, 2019
CompletedStudy Start
First participant enrolled
June 4, 2019
CompletedFirst Posted
Study publicly available on registry
September 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2019
CompletedSeptember 25, 2019
September 1, 2019
5 months
April 5, 2019
September 24, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain during local anaesthetic administration
Patient-rated pain intensity during administration of local anaesthetic via each route (transconjunctival and transcutaneous), expressed on a 0-10 scale (0 being no pain at all and 10 being the worst pain possible)
During local anaesthetic administration (2-3 minutes)
Secondary Outcomes (3)
Requirement for additional anaesthetic
During surgical procedure (up to 1 hour)
Bruising after local anaesthetic
Immediately after local anaesthetic (2-5 minutes)
Other complications
During anaesthetic administration, surgery, or up until the first postoperative visit (2-3 weeks later)
Study Arms (2)
Transcutaneous anaesthetic
ACTIVE COMPARATORTransconjunctival anaesthetic
ACTIVE COMPARATORInterventions
Topical anaesthetic drops (proxymetacaine 0.5% and tetracaine 1%) applied
Local anaesthetic (50/50 mixture of bupivacaine 0.5% / lidocaine 2% with adrenaline 1:200 000) administered to the eyelid via the transconjunctival route
Local anaesthetic (50/50 mixture of bupivacaine 0.5% / lidocaine 2% with adrenaline 1:200 000) administered to the eyelid via the transcutaneous route
The patient will be asked to rate the level of pain during each local anaesthetic injection on a 0-10 scale
The patient will have a photograph taken following the anaesthetic injections to document the presence or absence of bruising
Eyelid surgery will be performed as per the plan from their preoperative appointment
Eligibility Criteria
You may qualify if:
- patients undergoing bilateral oculoplastic procedures under local anaesthesia on selected lists at Southampton General Hospital or Lymington New Forest Hospital, UK
- able to give informed consent and adhere to the study protocol
You may not qualify if:
- patients undergoing substantially different procedures on each eye
- patients undergoing procedures not amenable to the administration of anaesthetic via the transconjunctival route (e.g. brow lift)
- patients undergoing a first procedure on one eye and a 'redo' procedure on the fellow eye (as the presence of scar tissue on the previously operated eye is likely to affect results)
- patients having their procedure under general anaesthesia, or receiving intravenous sedation prior to the administration of local anaesthetic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, SO16 5JT, United Kingdom
Related Publications (1)
Jawad M, Chow K, Nicholson R, Jonas A, Siah WF. Transconjunctival versus transcutaneous local anaesthetic administration for lower eyelid surgery: a randomised controlled trial. Eye (Lond). 2022 May;36(5):1094-1099. doi: 10.1038/s41433-021-01588-w. Epub 2021 Jun 11.
PMID: 34117385DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
We Fong Siah
University Hospitals Southampton NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 5, 2019
First Posted
September 25, 2019
Study Start
June 4, 2019
Primary Completion
October 30, 2019
Study Completion
November 30, 2019
Last Updated
September 25, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share